We also examined whether blocking microglial glutamate release improved cognitive dysfunction in an AD mouse model using transgenic mice expressing mutant variants of human amyloid precursor protein (APP) and presenilin 1 (PS1) (APP/PS1 Tg mice). This evidence concerns the gene APP and Alzheimer disease.